Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Scientific Officer
-
Stock Symbol
-
ACRS on Nasdaq
Joseph Monahan - trading volume in the past year for Aclaris Therapeutics, Inc.
Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
Common Stock |
187K |
$232K |
$1.24 |
Mar 2, 2024 |
Direct |
|
|
Common Stock |
193 |
$241 |
$1.25 |
Mar 1, 2024 |
By Spouse |
|
|
Restricted Stock Units |
0 |
$0 |
$1.25 |
Mar 2, 2024 |
Direct |
Common Stock |
|
Employee Stock Option (Right to Buy) |
207K |
|
|
Feb 1, 2024 |
Direct |
Common Stock |
|
Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.